2025
$5.07
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$686.7M; dWC=$-66.8M (sum of all 'changes in assets and liabilities' lines in cash-flow statement; negative = cash use); SBC=$61.0M; capex=$79.2M, growth capex=$4.5M (0.84% avg capex/revenue x revenue change $528.8M), maintenance capex=$74.8M; OE=$617.8M; diluted shares=121.932M; OE/sh=$5.07. Source: FY2025 10-K, accession 0001628280-25-053316. Scope: first full year after CMS spin (continuing business); NI+non-cash reconciliation ties exactly (753.5).
2024
$4.91
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$1,054.7M; dWC=$247.2M (sum of all 'changes in assets and liabilities' lines in cash-flow statement; negative = cash use); SBC=$74.2M; capex=$121.1M, growth capex=$5.5M (0.84% avg capex/revenue x revenue change $649.5M), maintenance capex=$115.6M; OE=$617.6M; diluted shares=125.881M; OE/sh=$4.91. Source: FY2025 10-K, accession 0001628280-25-053316. Scope: consolidated CFO incl. CMS to its Sept 27, 2024 spin; growth capex on continuing revenue 10,851.4 to 11,500.9.
2023
$6.92
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$974.8M; dWC=$-105.2M (sum of all 'changes in assets and liabilities' lines in cash-flow statement; negative = cash use); SBC=$74.3M; capex=$137.5M, growth capex=$12.1M (0.84% avg capex/revenue x revenue change $1,429.6M), maintenance capex=$125.4M; OE=$880.2M; diluted shares=127.214M; OE/sh=$6.92. Source: FY2025 10-K, accession 0001628280-25-053316. Scope: consolidated incl. CMS (discontinued); revenue pair 14,922.8 vs 16,352.4 consolidated as reported.
2022
$8.39
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$474.7M; dWC=$-785.2M (sum of all 'changes in assets and liabilities' lines in cash-flow statement; negative = cash use); SBC=$53.4M; capex=$127.6M, growth capex=$7.0M (0.84% avg capex/revenue x revenue change $830.2M), maintenance capex=$120.6M; OE=$1,085.9M; diluted shares=129.445M; OE/sh=$8.39. Source: FY2022 10-K, accession 0000052988-22-000111. Scope: consolidated incl. CMS; accrued-liabilities outflow of $552.0M treated as working capital; NI+non-cash reconciliation ties exactly (1,259.9).
2021
$5.14
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$726.3M; dWC=$-93.6M (sum of all 'changes in assets and liabilities' lines in cash-flow statement; negative = cash use); SBC=$56.2M; capex=$92.8M, growth capex=$4.4M (0.84% avg capex/revenue x revenue change $525.7M), maintenance capex=$88.4M; OE=$675.3M; diluted shares=131.274M; OE/sh=$5.14. Source: FY2022 10-K, accession 0000052988-22-000111. Scope: consolidated incl. CMS; PA Consulting 65% from March 2021.
2020
$6.38
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$806.8M; dWC=$-199.2M (sum of all 'changes in assets and liabilities' lines in cash-flow statement; negative = cash use); SBC=$48.1M; capex=$118.3M, growth capex=$7.0M (0.84% avg capex/revenue x revenue change $829.1M), maintenance capex=$111.3M; OE=$846.7M; diluted shares=132.721M; OE/sh=$6.38. Source: FY2022 10-K, accession 0000052988-22-000111. Scope: consolidated incl. CMS (spun Sept 2024).
2019
-$0.59
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$-366.4M; dWC=$-489.1M (sum of all 'changes in assets and liabilities' lines in cash-flow statement; negative = cash use); SBC=$69.1M; capex=$136.0M, growth capex=$0 (revenue declined), maintenance capex=$136.0M; OE=$-82.5M; diluted shares=139.206M; OE/sh=$-0.59. Source: FY2019 10-K, accession 0000052988-19-000069. Scope: consolidated incl. ECR to April 2019 sale (CFO depressed by taxes/costs on ECR sale) and CMS; revenue FY19 continuing 12,737.9 < FY18 14,984.6 so growth capex 0.
2018
$4.71
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$481.2M; dWC=$-299.2M (sum of all 'changes in assets and liabilities' lines in cash-flow statement; negative = cash use); SBC=$79.2M; capex=$94.9M, growth capex=$41.8M (0.84% avg capex/revenue x revenue change $4,961.9M), maintenance capex=$53.0M; OE=$648.1M; diluted shares=137.536M; OE/sh=$4.71. Source: FY2019 10-K, accession 0000052988-19-000069. Scope: consolidated incl. CH2M from Dec 2017, ECR and CMS; revenue pair FY17 10,022.8 vs FY18 14,984.6 as reported.
2017
$2.60
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$574.9M; dWC=$105.4M (sum of all 'changes in assets and liabilities' lines in cash-flow statement; negative = cash use); SBC=$38.8M; capex=$118.1M, growth capex=$0 (revenue declined), maintenance capex=$118.1M; OE=$312.7M; diluted shares=120.147M; OE/sh=$2.60. Source: FY2019 10-K, accession 0000052988-19-000069. Scope: consolidated, includes ECR (sold April 2019) and CMS (spun Sept 2024).
2016
$2.31
▼
OE = CFO - dWC - SBC - maintenance capex. CFO=$680.2M; dWC=$299.7M (sum of all 'changes in assets and liabilities' lines in cash-flow statement; negative = cash use); SBC=$32.4M; capex=$67.7M, growth capex=$0 (revenue declined), maintenance capex=$67.7M; OE=$280.4M; diluted shares=121.483M; OE/sh=$2.31. Source: FY2016 10-K, accession 0001564590-16-029571. Scope: consolidated, includes Energy, Chemicals & Resources (sold 2019) and Critical Mission Solutions (spun to Amentum 2024).
Owner's earnings per share by fiscal year, most recent first. Tap a row to see how that figure was calculated, including the source filing.